Home Contact

logo

Family

Links:






Archives:


Newsletter:

Register for our Free monthly newsletter to receive timely updated information about Parkinsons Disease directly in your email.
Email
First Name
Last Name
Zip Code

Categories:



Register for our FREE monthly newsletter to receive timely updated information about Parkinsons Disease directly in your email.

Archive for January, 2008

Gamma Knife May Replace Surgery for Parkinson’s Disease

Friday, January 18th, 2008

Researchers at Jefferson Medical college of Thomas Jefferson University and Wills Eye Hospital, Philadelphia, are sidestepping surgery and using a device to deliver high doses of tissue-destroying radiation to tiny targets deep within the brain in the hopes of alleviating the symptoms of Parkinson’s disease.  Doctors hope that the noninvasive gamma knife will offer both reduced recovery time and shorter hospital stays for patients with Parkinson’s and other movement disorders whose symptoms cannot be controlled with medication.

At the 83rd Scientific Assembly and Annual Meeting of the Radiological Society of North America in Chicago, David P. Friedman, M.D., associate professor of radiology, Jefferson Medical College, reports results on December 3 of the first 12 Parkinson’s disease patients to undergo gamma knife treatment. Of those treated, seven showed marked improvement in their symptoms, three had moderate improvement and two showed mild improvement with a three-month follow-up. Dr. Friedman notes that such results are comparable to those of surgery. The patients in the study all were unable for various reasons to undergo conventional surgery.

The gamma knife uses magnetic resonance imaging to identify the radiosurgical target. The radiation destroys certain areas of the brain’s thalamus or globus pallidus, hoping to control tremors, rigidity or other involuntary movements.

According to H. Warren Goldman, M.D., Ph.D., professor and vice-chair, neurosurgery, Jefferson Medical College, and at Wills Eye Hospital, Philadelphia, as many as 50,000 patients a year could benefit from the treatment. Dr. Goldman, who notes “this is a relatively new use of the gamma knife,” says that doctors are so pleased with the technique’s results to date that they have begun offering the treatment as an alternative to other patients as well.

Nearly all patients with Parkinson’s eventually, within five to eight years, become refractory to treatment by medicine. When medication fails, doctors may treat Parkinson’s by two types of brain surgery. In a thalidotomy, surgeons remove or destroy tissue in thalamus, which controls tremors. In a pallidotomy, tissue in the globus pallidus is destroyed in an attempt to control rigidity and some involuntary movements.

The gamma knife has several advantages over surgery, according to Drs. Goldman and Friedman. The treatment is noninvasive, without the risks of bleeding or infection. Patients remain hospitalized for only 24 hours compared to three or more days with surgery. Recovery time from gamma knife treatment is minimal; recovery from surgery typically takes at least two weeks.

The treatment has some downsides, however. Whereas surgery results are almost immediate, gamma knife treatment results take time, and may not be known for perhaps as long as six or eight weeks.

The gamma knife is primarily used to treat brain tumors and various vascular malformations. “This expands its uses,” Dr. Friedman says. “Though some 90 centers worldwide, including 32 centers in the United States, have the gamma knife, only perhaps a handful use them this way.” Jefferson and Wills began using the gamma knife to treat Parkinson’s in July 1996. Dr. Goldman believes that it is the only such device in the Philadelphia area.

Source: http://www.sciencedaily.com/releases/1997/12/971205073454.htm

Lee Silverman Voice Therapy Demonstrates Great Value

Friday, January 18th, 2008

Dysarthria, the difficulty of speaking and dysphagia, the difficulty of swallowing can be limiting symptoms of Parkinson’s disease and can be helped through a speech pathologist.  A new program called the Lee Silverman Voice Therapy Program, has been developed and has demonstrated great value to those with Parkinson’s disease.

The Lee Silverman Voice Therapy Program helps reverse the decline of patients speech by focusing on increasing volume through a set of intense exercises.

For questions in regards to Lee Silverman Voice Therapy click here.

My Parkinson’s Information’s Role in Your Care

Friday, January 18th, 2008

When someone is diagnosed with Parkinson’s disease sometimes it is difficult to track down all of the information that is out there. My Parkinson’s Information was created to bring all the research and news about Parkinson’s to one central place. My Parkinson’s Information is also a website where people can come and learn and gain support from others that are going through similar things.

We do not replace your doctor. Your doctor is an important part of your life. It’s also very important to have someone to be accountable to. Doctors are wonderful sources as you decide what treatments and medications to use. Take the time and build a relationship with you doctor, it’s worth it!  To learn more about our purpose please visit our FAQs.

We look forward to serving you and look forward to hearing from you soon. Please keep us informed of your progression, set-backs and other important information so that we can bless the rest of the Parkinson’s community.

Sincerely,

Caleb Manscill

caleb@imedmarkets.com

Combating Parkinson’s Disease

Thursday, January 17th, 2008

I Just read about a man who has claimed to stop the progression of Parkinson’s disease by focusing on taking care of himself. Some of the things he mentioned that helped him stop the progression of Parkinson’s include regular exercise, eating well to get well, consistent hydration, laughter, and laughter.

This focus sounds very familiar to Dr. David Heydrick’s Parkinson’s Pyramid. Dr. David Heydrick’s Pyramid is similar to the food pyramid in that there are certain servings of activities that should be taken in daily such as exercise, eating, laughing, and stress relief. I find it very interesting that both of these individuals have found similar practices that have both brought profound results.

With this said I realize that these techniques are not novel, in fact they are very much expected whether we have Parkinson’s disease or not, but far too often I believe we forget the simple things in life and worry a little too much about the things we cannot control. The beautiful thing about the things listed above is that we do have control over these parts of our life. I would love hear other stories of patients with Parkinson’s that have emphasized exercise, balanced diet, laughter, and stress relief in combating Parkinson’s disease–email me at caleb@imedmarkets.com.

Method Predicts ALS and Parkinson’s Disease

Thursday, January 17th, 2008

A new Mayo Clinic study details an unprecedented method to predict brain aging disorders such as amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease) and Parkinson’s disease. Investigators studied common variations within axon guidance pathway genes and identified several gene variations (DNA fingerprints) that collectively predicted people who are at a high risk for ALS (2,000 times greater than the average risk). They also identified several gene variations that collectively predicted people at a high risk for Parkinson’s disease (nearly 400 times greater than the average risk).

The probability that the findings were by chance was extremely small (less than one in a trillion). The axon guidance pathway consists of a complex array of chemical signals that wires the brain during fetal development and maintains and repairs brain wiring throughout life.

“The mission of our research is to predict, prevent and halt brain aging disorders,” explains Demetrius Maraganore, M.D., Mayo Clinic neurologist and principal investigator. “I envision a day when we will be able to do a simple blood test and predict whether a person is at high risk to develop brain aging disorders such as ALS, Parkinson’s disease and even Alzheimer’s disease by studying common gene variations in disease pathways. In persons at high risk, we may be able to prevent the diseases or slow or halt their progression by developing drugs that target the same disease pathways. For ALS and Parkinson’s disease, our study is a major step in these directions.”

About the Study
In June 2007, the investigators reported similar findings for Parkinson’s disease. However, with this new study they extended their findings to
ALS, where they observed greater effects. The investigators noted that while up to 50 percent of the axon guidance pathway genes that predict ALS or Parkinson’s disease are in common, there also are gene variations that are specific to either disease. This may help explain the similarities and differences that are seen in persons with these diseases, or the clustering of such diseases that sometimes occur within isolated populations or families.

The investigators obtained these results by analyzing publicly available datasets of whole-genome variations in people with ALS, Parkinson’s disease and those who did not have neurological disorders. The datasets were released recently by the Coriell Institute and the National Institutes of Health. The investigators developed and applied to the data a genomic pathways approach.

“The size of the effects that were observed and their statistical significance are unprecedented in the study of brain aging disorders. I attribute our success to the genomic pathways approach we developed,” adds Timothy Lesnick, Mayo Clinic biostatistician. “Now we need to develop a better map of the gene variations within the axon guidance pathway and make comparisons across multiple brain aging diseases and populations.”

ALS causes degeneration of the nerve cells in certain regions of the brain and spinal cord that control a person’s voluntary muscles. Eric Sorenson, M.D., and Eric Ahlskog, M.D., Ph.D., Mayo Clinic neurologists specializing in ALS and movement disorders, agree that impairments in brain wiring and repair are plausible causes of ALS and Parkinson’s disease. Investigators agree that additional research is needed to continue the success obtained in this study.

“I envision experiments in cultured cells and animal models to define the most important treatment targets within the axon guidance pathway,” says John Henley, Ph.D., Mayo Clinic neuroscientist and expert on brain wiring and repair processes.

The study was conducted primarily by the Mayo Clinic investigators, with bioinformatic support from Spiridon Papapetropoulos, M.D., Ph.D., and Lina Shehadeh, Ph.D., at the Miller School of Medicine, University of Miami.

About ALS
Amyotrophic lateral sclerosis causes degeneration of the nerve cells in certain regions of the brain and spinal cord that control a person’s voluntary muscles. Patients eventually lose the ability to move their limbs and control muscles needed to breathe. It is estimated that 30,000 Americans are living with the disease.

About Parkinson’s disease
Parkinson’s disease is an aging-related disorder that affects nearly a million Americans. The cardinal signs include tremors, slowness of movements and rigid body and limbs. The symptoms predominantly arise from progressive degeneration of brain cells that produce the chemical dopamine.

Background information
The study was recently published online in the public access journal PLoS One. 

This work was supported in part by grants from the National Institutes of Health (R01 ES10751 to DMM), and the Michael J. Fox Foundation (Linked Efforts to Accelerate Parkinson Solutions award to DMM). The funders had no role in the design and conduct of the study; in the collection, analysis and interpretation of the data; and in the preparation, review or approval of the manuscript.

In accordance with the Bayh-Dole Act of 1980, Mayo Clinic has filed a provisional patent for 37 CFR (section sign) 1.53 (c) entitled ‘Predicting Parkinson’s disease.’ Dr. Maraganore and Mr. Lesnick are the inventors of the technology used in this research, and they and Mayo Clinic have a potential financial interest in that technology. No monies have been awarded to date.

Stephanie Assuras: Emotional Stimuli and Motor Responses in Parkinson’s Disease

Thursday, January 17th, 2008

Speaker: Stephanie Assuras, Graduate Center & Queens College, CUNY.

Besides impairing motor functioning, does Parkinson’s disease (PD) impair emotional processing? Preliminary research suggests it does. The research reported here examined how viewing emotional pictures, including pleasant, unpleasant, or arousing content, affected motor responses of patients with PD, and tested whether the effect of emotion interacted with the presence or absence of dopaminergic medication. PD patients had slower than normal reaction times overall, but different types of emotional pictures affected them the same way they affected control subjects, so PD may not be impairing emotional processing specifically, at least in early-to-moderate stages of PD. Motor functions were better with medication, but reaction times were slower and there were fewer accurate responses in memory testing. It may be that slower reactions with medication involves cognitive function, rather than motor function, and further investigation of this might provide a basis for optimal pharmacological strategies for PD.

Lecture begins after a few minutes devoted to a report to NYNG members and their responses to it, but the entire meeting is open to all, and no fee or pre-registration is required.

To receive more information please click here.

Nose Knows Parkinson’s Disease

Tuesday, January 15th, 2008

Parkinson’s Disease Smell TestImagine going to the doctors office for your annual check-up. You get the usual of weighing in, measuring your blood pressure, calculating your heart rate and then measuring your smell to see if you may have Parkinson’s disease… Doctors and researchers have known for quite a while that an impaired sense of smell may be an early indicator of Parkinson’s disease. Doctor Kapil Sethi is conducting a smell test for people who’s parents or siblings have had Parkinson’s disease.

Presently Parkinson’s disease is diagnosed through motor symptoms like tremors, stiffness, and slowness in order to diagnose it. Which, by that point 50 to 60% of dopaminergic cells have been lost. Dopamine cells are key to movement control. The smell test is being tested to see if there is a way to diagnose Parkinson’s disease at a much earlier stage so that Parkinson’s disease can possibly be stopped earlier.

Doctor Kapil Sethi, director of the Movement Disorders Program at the Medical College of Georgia and a lead investigator for the Parkinson’s Associated Risk Syndrome Study, is leading the study. The study is being conducted at 17 sites across the country. The study is trying to recruit15,00 close relatives of Parkinson’s patients.

Science Daily reports on some of the details of the study, “Patients will be given the University of Pennsylvania’s Smell Identification Test, which tests for 40 common odors and has been used to detect the first signs of neurodegenerative disorders.

People with a normal sense of smell who take the test can usually identify around 35 odors correctly. Parkinson’s patients typically can only identify 20 or less.

The study will also help determine if the smell test can also predict who will get Parkinson’s. ‘We believe that if you’re a person who is going to develop Parkinson’s, you’ll also score lower than others,’ Dr. Sethi says.”

The study is open to those 50 or older who do not have Parkinson’s but have a mother, father, child or sibling with the disease. For more information, call the MCG Movement Disorders Program at 706-721-2798 or the Institute for Neurodegenerative Disorders 877-401-4300.